Related references
Note: Only part of the references are listed.Establishing clinical remission criteria and the framework of a treat-to-target algorithm for Takayasu arteritis: Results of a Delphi exercise carried out by an expert panel of the Japan Research Committee of the Ministry of Health, Labour and Welfare for intractable vasculitis
Takahiko Sugihara et al.
MODERN RHEUMATOLOGY (2022)
Global epidemiology of vasculitis
Richard A. Watts et al.
NATURE REVIEWS RHEUMATOLOGY (2022)
Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study
Xiufang Kong et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG-PET/CT: a Chinese cohort study
Ling-Ying Ma et al.
RHEUMATOLOGY (2022)
PET in Takayasu arteritis: onwards and upwards towards a future of robust multimodality disease activity assessment?
Corrado Campochiaro et al.
RHEUMATOLOGY (2022)
Extended-release tofacitinib improves refractory Takayasu's arteritis
C-R Wang et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2022)
Survival and causes of death for Takayasu's arteritis in Korea: A retrospective population-based study
Shin Yi Jang et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)
Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study
Lourdes Ortiz-Fernandez et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2021)
Takayasu's arteritis and acute type B aortic dissection treated with a stent graft
E. Mazumdar et al.
VASCULAR (2021)
Biologic treatments in Takayasu's Arteritis: A comparative study of tumor necrosis factor inhibitors and tocilizumab
Fatma Alibaz-Oner et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Specific Follicular Helper T Cell Signature in Takayasu Arteritis
A. C. Desbois et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Disease-modifying anti-rheumatic drugs for the management of Takayasu arteritis-a systematic review and meta-analysis
Durga Prasanna Misra et al.
CLINICAL RHEUMATOLOGY (2021)
Application progress of multiple imaging modalities in Takayasu arteritis
Shanshan Jia et al.
INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2021)
CD8+ T lymphocyte is a main source of interferon-gamma production in Takayasu's arteritis
Yan-Long Ren et al.
SCIENTIFIC REPORTS (2021)
A susceptibility locus in the IL12B but not LILRA3 region is associated with vascular damage in Takayasu arteritis
Keiichiro Kadoba et al.
SCIENTIFIC REPORTS (2021)
Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease
Debashish Danda et al.
RHEUMATOLOGY (2021)
Factors associated with event-free survival in Chinese patients with Takayasu's arteritis
Yu Wei et al.
CLINICAL RHEUMATOLOGY (2021)
Signal intensity of superb micro-vascular imaging associates with the activity of vascular inflammation in Takayasu arteritis
Shinichiro Ito et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2020)
Efficacy and safety of leflunomide treatment in Takayasu arteritis: Case series from the East China cohort
Xiaomeng Cui et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Surgery and Endovascular Management in Patients With Takayasu's Arteritis: A Ten-Year Retrospective Study
Yongpeng Diao et al.
ANNALS OF VASCULAR SURGERY (2020)
Targeting Mechanistic Target of Rapamycin Complex 1 Restricts Proinflammatory T Cell Differentiation and Ameliorates Takayasu Arteritis
Jifeng Zhang et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America
Ruchika Goel et al.
RHEUMATOLOGY (2020)
Circulatory Glutamine/Glucose ratio for evaluating disease activity in Takayasu arteritis: A NMR based serum metabolomics study
Umesh Kumar et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2020)
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study
Yoshikazu Nakaoka et al.
RHEUMATOLOGY (2020)
Drug retention and discontinuation reasons between seven biologics in patients with Takayasu arteritis
Corrado Campochiaro et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2020)
Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis
Saki Kuwabara et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Targeting JAK/STAT pathway in Takayasu's arteritis
Paul Regnier et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Identification of two major autoantigens negatively regulating endothelial activation in Takayasu arteritis
Tomoyuki Mutoh et al.
NATURE COMMUNICATIONS (2020)
Performance of the PET vascular activity score (PETVAS) for qualitative and quantitative assessment of inflammatory activity in Takayasu's arteritis patients
Fei Kang et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2020)
Tofacitinib in patients with refractory Takayasu's arteritis
Jing Li et al.
RHEUMATOLOGY (2020)
Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis
Chunling Wu et al.
THERAPEUTIC ADVANCES IN CHRONIC DISEASE (2020)
Letter to the Editor (Case report)
Yuriko Yamamura et al.
RHEUMATOLOGY ADVANCES IN PRACTICE (2020)
Takayasu arteritis: advanced understanding is leading to new horizons
Enrico Tombetti et al.
RHEUMATOLOGY (2019)
Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patients
Adrien Mirouse et al.
JOURNAL OF AUTOIMMUNITY (2019)
Contrast-enhanced Ultrasonography for Monitoring Arterial Inflammation in Takayasu Arteritis
ZhiQin Li et al.
JOURNAL OF RHEUMATOLOGY (2019)
PET/MRI in large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity
Charlotte Laurent et al.
SCIENTIFIC REPORTS (2019)
Translation and validation of the Indian Takayasu clinical activity score (ITAS2010) for the Brazilian Portuguese language
Scheila Fritsch et al.
ADVANCES IN RHEUMATOLOGY (2019)
Magnetic resonance angiography versus 18F-fluorodeoxyglucose positron emission tomography in large vessel vasculitis
Daniel Blockmans et al.
AUTOIMMUNITY REVIEWS (2019)
Pathophysiology of large vessel vasculitis and utility of interleukin-6 inhibition therapy
Hajime Yoshifuji
MODERN RHEUMATOLOGY (2019)
Visualization of arterial wall vascularization using superb microvascular imaging in active-stage Takayasu arteritis
Wakana Sato et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2019)
Value of contrast-enhanced ultrasonography of the carotid artery for evaluating disease activity in Takayasu arteritis
Ling-Ying Ma et al.
ARTHRITIS RESEARCH & THERAPY (2019)
C-reactive protein gene polymorphisms (rs1205) in Asian Indian patients with Takayasu arteritis: Associations and phenotype correlations
Aswin M. Nair et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Soluble-HLA-E: A follow up biomarker in Takayasu arteritis, independent of HLA-E genotype
Ruchika Goel et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature
Giulia Pazzola et al.
RHEUMATOLOGY (2018)
Study of serial serum myeloid-related protein 8/14 as a sensitive biomarker in Takayasu arteritis: a single centre study
Ruchika Goel et al.
RHEUMATOLOGY INTERNATIONAL (2018)
Renal Autotransplantation with Autologous Saphenous Vein Graft in a Patient with Takayasu Arteritis and Existing Renal Artery Stent in Her Solitary Kidney
Hakan Bahadir Haberal et al.
UROLOGIA INTERNATIONALIS (2018)
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
Christian Dejaco et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Imaging modalities for the diagnosis and disease activity assessment of Takayasu's arteritis: A systematic review and meta-analysis
Lillian Barra et al.
AUTOIMMUNITY REVIEWS (2018)
Carbon dioxide Angiography-Guided Renal-Related Interventions in Patients with Takayasu Arteritis and Renal Insufficiency
Sujith Chacko et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Serum BAFF and APRIL levels in Indian patients with Takayasu arteritis
Abhishek Zanwar et al.
CLINICAL RHEUMATOLOGY (2018)
Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy
Berit Dalsgaard Nielsen et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2018)
Endovascular Versus Open Surgical Intervention in Patients with Takayasu's Arteritis: A Meta-analysis
Jae Hyun Jung et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2018)
Long-term outcome of 251 patients with Takayasu arteritis on combination immunosuppressant therapy: Single centre experience from a large tertiary care teaching hospital in Southern India
Ruchika Goel et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2018)
18F-Fluorodeoxyglucose-Positron Emission Tomography As an Imaging Biomarker in a Prospective, Longitudinal Cohort of Patients With Large Vessel Vasculitis
Peter C. Grayson et al.
ARTHRITIS & RHEUMATOLOGY (2018)
Surgical intervention and its role in Takayasu arteritis
Justin C. Mason
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2018)
Genetic determinants and an epistasis of LILRA3 and HLA-B☆52 in Takayasu arteritis
Chikashi Terao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Single-Nucleotide Polymorphism of the MLX Gene Is Associated With Takayasu Arteritis
Natsuko Tamura et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
EXTRAVASCULAR MANIFESTATIONS OF TAKAYASU ARTERITIS: HISTORICAL COHORT STUDY IN KOREA
O. C. Kwon et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Efficacy and safety of tocilizumab in patients with refractory Takayasu arteritis: results from a randomised, double-blind, placebo-controlled, phase 3 trial in Japan (the TAKT study)
Yoshikazu Nakaoka et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Relationship of HLA-B*51 and HLA-B*52 alleles and TNF-α-308A/G polymorphism with susceptibility to Takayasu arteritis: a meta-analysis
Si Chen et al.
CLINICAL RHEUMATOLOGY (2017)
Association of FCGR2A/FCGR3A variant rs2099684 with Takayasu arteritis in the Han Chinese population
Si Chen et al.
ONCOTARGET (2017)
18F-FDG PET reveals unique features of large vessel inflammation in patients with Takayasu's arteritis
Elena Incerti et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
Correlating MRI with clinical evaluation in the assessment of disease activity of Takayasu's arteritis
Reetu A. John et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Vascular surgery: the main risk factor for mortality in 146 Takayasu arteritis patients
Nilton Salles Rosa Neto et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Analysis of the common genetic component of large-vessel vasculitides through a meta-Immunochip strategy
F. David Carmona et al.
SCIENTIFIC REPORTS (2017)
Aortic Aneurysm in Takayasu Arteritis
Kun-Qi Yang et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2017)
Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis A Multicenter Study of 318 Patients
Cloe Comarmond et al.
CIRCULATION (2017)
Takayasu arteritis: an update
Emire Seyahi
CURRENT OPINION IN RHEUMATOLOGY (2017)
A novel susceptibility locus for Takayasu arteritis in the IL12B region can be a genetic marker of disease severity
Takayoshi Matsumura et al.
HEART AND VESSELS (2016)
Childhood-onset Takayasu arteritis: an update
Ashish J. Mathew et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2016)
Revisited HLA and non-HLA genetics of Takayasu arteritis-where are we?
Chikashi Terao
JOURNAL OF HUMAN GENETICS (2016)
Biotherapies in large vessel vasculitis
Y. Ferfar et al.
AUTOIMMUNITY REVIEWS (2016)
IL-9-producing Th9 cells may participate in pathogenesis of Takayasu's arteritis
Li-li Pan et al.
CLINICAL RHEUMATOLOGY (2016)
Lack of association between polymorphisms in interleukin (IL)-12, IL-12R, IL-23, IL-23R genes and Takayasu arteritis in a Chinese population
Kun-Qi Yang et al.
INFLAMMATION RESEARCH (2016)
Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results
Meng Peng et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Cause of death in Chinese Takayasu arteritis patients
Jing Li et al.
MEDICINE (2016)
Outcomes of different treatments on Takayasu's arteritis
Yu Xiao et al.
JOURNAL OF THORACIC DISEASE (2016)
The efficacy of Mycophenolate mofetil for the treatment of Chinese Takayasu's arteritis
Jing Li et al.
SCIENTIFIC REPORTS (2016)
Increased Circulating Th17 Cells, Serum IL-17A, and IL-23 in Takayasu Arteritis
Durga Prasanna Misra et al.
AUTOIMMUNE DISEASES (2016)
USTEKINUMAB AS A THERAPEUTIC OPTION FOR TAKAYASU ARTERITIS -FROM GENETIC FINDINGS TO CLINICAL APPLICATION
C. Terao et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Current Clinical Features of New Patients With Takayasu Arteritis Observed From Cross-Country Research in Japan Age and Sex Specificity
Yoshiko Watanabe et al.
CIRCULATION (2015)
Efficacy of Biological-Targeted Treatments in Takayasu Arteritis Multicenter, Retrospective Study of 49 Patients
Arsene Mekinian et al.
CIRCULATION (2015)
Takayasu arteritis: surgical interventions
Justin C. Mason
CURRENT OPINION IN RHEUMATOLOGY (2015)
Patients with Takayasu's arteritis having persistent acute-phase response usually have an increased major vessel uptake by 18F-FDG-PET/CT
Fatma Alibaz-Oner et al.
MODERN RHEUMATOLOGY (2015)
Optimizing the outcome of vascular intervention for Takayasu arteritis
A. H. Perera et al.
BRITISH JOURNAL OF SURGERY (2014)
Diagnostic and classification criteria of Takayasu arteritis
Alexandre Wagner Silva de Souza et al.
JOURNAL OF AUTOIMMUNITY (2014)
Clinical Manifestations and Longterm Outcome for Patients with Takayasu Arteritis in China
Lirui Yang et al.
JOURNAL OF RHEUMATOLOGY (2014)
Endovascular Treatment of Large Vessel Arteritis
John Fritz Angle et al.
TECHNIQUES IN VASCULAR AND INTERVENTIONAL RADIOLOGY (2014)
Two Susceptibility Loci to Takayasu Arteritis Reveal a Synergistic Role of the IL12B and HLA-B Regions in a Japanese Population
Chikashi Terao et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
Rapid control of disease activity by tocilizumab in 10 'difficult-to-treat' cases of Takayasu arteritis
Ruchika Goel et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2013)
The challenges in assessing Takayasu arteritis
Paul Bacon et al.
PRESSE MEDICALE (2013)
Outcome of 1516 percutaneous interventions in 401 patients with Takayasu arteritis - a single-center experience from South India
G. Joseph et al.
PRESSE MEDICALE (2013)
Development and initial validation of the Indian Takayasu Clinical Activity Score (ITAS2010)
Ramnath Misra et al.
RHEUMATOLOGY (2013)
Pathology of Takayasu arteritis: A brief review
Pradeep Vaideeswar et al.
ANNALS OF PEDIATRIC CARDIOLOGY (2013)
Retrospective Analysis of Surgery Versus Endovascular Intervention in Takayasu Arteritis A Multicenter Experience
David Saadoun et al.
CIRCULATION (2012)
Tocilizumab: a novel therapy for patients with large-vessel vasculitis
Carlo Salvarani et al.
RHEUMATOLOGY (2012)
Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study
A. W. S. de Souza et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
Takayasu's arteritis is associated with HLA-B*52, but not with HLA-B*51, in Turkey
Ziver Sahin et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Pathogenesis of Takayasu's arteritis: A 2011 update
Laurent Arnaud et al.
AUTOIMMUNITY REVIEWS (2011)
Circulating B lymphocytes producing autoantibodies to endothelial cells play a role in the pathogenesis of Takayasu arteritis
Haitao Wang et al.
JOURNAL OF VASCULAR SURGERY (2011)
Mycophenolate mofetil in Takayasu's arteritis
Ruchika Goel et al.
CLINICAL RHEUMATOLOGY (2010)
Takayasu arteritis-advances in diagnosis and management
Justin C. Mason
NATURE REVIEWS RHEUMATOLOGY (2010)
Assessment of disease activity and progression in Takayasu's arteritis with Disease Extent Index-Takayasu
Sibel Z. Aydin et al.
RHEUMATOLOGY (2010)
Absence of Mycobacterium tuberculosis in Arterial Lesions from Patients with Takayasus Arteritis
Laurent Arnaud et al.
JOURNAL OF RHEUMATOLOGY (2009)
Vessel-specific Toll-like receptor profiles in human medium and large arteries
Olga Pryshchep et al.
CIRCULATION (2008)
Antiendothelial cell antibodies in vasculitis and connective tissue disease
C. Belizna et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Takayasu's arteritis: Operative results and influence of disease activity
CE Fields et al.
JOURNAL OF VASCULAR SURGERY (2006)
Pyoderma gangrenosum associated with Takayasu's arteritis
H Ujiie et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2004)
Expression of costimulatory molecules (4-1BBL and Fas) and major histocompatibility class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis
Y Seko et al.
JOURNAL OF VASCULAR RESEARCH (2004)
Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis
SK Chauhan et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
Sonographic and color Doppler findings in aortoarteritis (Takayasu arteritis)
N Chaubal et al.
JOURNAL OF ULTRASOUND IN MEDICINE (2004)
Long-term survival after surgical treatment of patients with Takayasu's arteritis
T Miyata et al.
CIRCULATION (2003)
Utility and limitations of magnetic resonance imaging in diagnosis and treatment
E Tso et al.
ARTHRITIS AND RHEUMATISM (2002)
Granuloma formation, implications for the pathogenesis of vasculitis
MC Sneller
CLEVELAND CLINIC JOURNAL OF MEDICINE (2002)
Accumulation of lymphocytes, dendritic cells, and granulocytes in the aortic wall affected by Takayasu's disease
SJ Inder et al.
ANGIOLOGY (2000)
Share Paper
